Among all patients with von Willebrand disease (vWD), alloantibodies to von Willebrand factor (vWF) have been described only in severe vWD (type III). The relationship between the development of alloantibodies and the nature of the genetic lesion in vWD is not known. In hemophilia B, large deletions within the factor IX gene appear to correlate with the occurrence of alloantibodies, whereas in hemophilia A no such correlation is apparent. We have studied 19 patients with severe recessive vWD (type III) and 19 with autosomal dominant vWD (type I) by Southern blotting with probes encompassing the full 9 kilobases (kb) of the vWF cDNA. Two apparently unrelated patients were shown to have large deletions within the vWF gene. Both patients had severe vWD (type HI) and were the only patients among those studied that had inhibitory alloantibodies to vWF. The extent of deletion was similar in both patients, corresponding to at least the 3'-7.4 kb of the vWF cDNA. The deletion in each patient was estimated to exceed 110 kb. In addition, the localization of the vWF gene to chromosome 12 was confirmed, and a homologous sequence on chromosome 22 was identified.
Introduction
Von Willebrand factor (vWF)' is a complex glycoprotein that is required for platelet adhesion to sites of vascular damage (1) and for normal factor VIII survival in circulation (2) . Human vWF is composed of identical subunits of Mr -250,000 that are assembled into multimers ranging from dimers to species with Mr > 10,000,000 (reviewed in 3). It is synthesized in endothelial cells (4, 5) and megakaryocytes (6) and is found in platelet a-granules and subendothelial connective tissue as well as in plasma (1) . The sequence of the vWF precursor has been determined by protein (7) and complementary DNA (cDNA) sequencing (8) (9) (10) (11) (12) (13) (14) (15) . The messenger RNA (mRNA) is 9.0 kilPortions ofthis work have been presented in abstract form (1986. (13) (14) (15) . The mature vWF subunit consists of 2,050 amino acids, and the protein sequence contains four types of repeated domains indicating a complex evolutionary history (8, 12, 14) . The vWF gene has been localized to human chromosome 112p12pr ( (12) . Probe III is a 2.8-kb Fsp I-Sac I fragment of XHvWF3 that encodes amino acids 544-1461 of vWF (8) . Probe IV is a 1.8-kb Sac I-Sac I fragment of XHvWF3 that encodes amino acids 1462-2050 (carboxy-terminus) of vWF. Probe IV also contains 127 out of the total 137 nucleotides of 3'-noncoding sequence (8) . Probes were labeled either by nick translation (25) Human chromosome suspensions were prepared from a lymphocyte cell line in Tris-spermine buffer and stained with DIPI and chromomycin A3 (27) . 30,000 chromosomes of each type were sorted using a duallaser fluorescence-activated cell sorter and spotted onto a nitrocellulose filter. The filters were processed and hybridized to cDNA probes, and signals were detected by autoradiography as previously described (27) . The final stringent washing condition was 0.1 X standard saline citrate (SSC), 0.1% (wt/vol) sodium dodecyl sulfate (SDS), for 45 min at 65°C (1 X SSC is 0.15 M NaCl, 0.015 M sodium citrate, pH 7.0).
Sufficient human chromosome 22 was purified as described in the preceeding paragraph for restriction enzyme digestion and Southern blotting. DNA was also prepared from a mouse-human hybrid cell line containing human chromosome 12 but not chromosomes 9-11 or 22, and also from a mouse-human hybrid cell line containing human chromosome 22. Aliquots of DNA were digested with restriction enzymes as indicated in specific figure legends, electrophoresed on 1% agarose gels in 1 X Tris-acetate-EDTA buffer (TAE), transfered to nitrocellulose filters, prehybridized, and hybridized to cDNA probes (25) . The (28) and aliquots were digested with Eco RI. Digested DNA was extracted with phenol/chloroform, precipitated with ethanol, dissolved in 10 mM Tris-Cl, pH 8.0, 1 mM EDTA, and quantitated by fluorometric assay (29, 30 ). -7-10 Mg was electrophoresed on a 1% agarose gel in 1 X Trisborate-EDTA buffer (TBE) (25) and transferred to GeneScreen Plus under alkaline conditions in 0.4 M NaOH, 0.6 M NaCi (31) . The membrane was neutralized for 15 min in 0.5 M Tris-Cl, pH 7, 1 M NaCl, and dried at 550C for 20 min. The membranes were prehybridized in 50 mM TrisCl, pH 7.5, 1 M NaCl, 200 ug/ml yeast transfer RNA for 30 min at 650C. The prehybridization solution was then supplemented with 10% dextran sulphate, 1% SDS, 200 ;g/ml salmon sperm DNA, and 32p_ labeled probe at 106 cpm/ml. Filters were subjected to a final stringent wash in 0.2 X SSC, 1% SDS for 15-60 min at 650C, and rinsed in 0.1 X SSC. The wet blots were wrapped in plastic wrap and exposed to XAR-5 film (Eastman Kodak Co., Rochester, NY) at -700C with one intensifying screen. The autoradiographs were developed after 3-10 d of exposure.
Results cDNA probes for human vWF Nonoverlapping cDNA probes were prepared that span the full length ofthe vWF mRNA (Fig.  1) . Four probes (I-IV) were used to screen DNA from patients with vWD for evidence ofgene deletion and restriction fiagment length polymorphism. Subfragments of probe I (IA, B, and C) were prepared to better define the 5'-extent of gene deletions in two patients, and to clarify the chromosomal origin of specific bands detected in Southern blots of patient and control DNA.
Localization ofthe vWFgene to chromosome 12 and related sequences to chromosome 22. The characterization of the vWF gene by Southern blotting is complicated by the presence of at least two loci in the human genome that hybridize to segments of the vWF cDNA. Restriction fragments of 3.0 kb or less from the 3'-end of the cDNA have been used previously to localize the vWF gene to human chromosome 12 (9, 11) . This localization was reexamined using probes spanning the full length of the vWF cDNA. Human chromosomes labeled with intercalating dyes were sorted with a fluorescence-activated cell sorter, yielding homogeneous preparations of all human chromosomes except for chromosomes 9-12 and 14-15, which were isolated as mixtures. Probes from the 5'-end (probe IC) and 3'-end ofthe cDNA (probe IV, Fig. 1 ) were shown to hybridize only to chromosomes 9-12 ( Fig. 2 , probes IC and IV). Probe III hybridized to the chromosome 9-12 spot, but also hybridized to chromosome 22 under conditions of very high stringency (Fig. 2, probe III) . The remaining autosomes and both sex chromosomes were negative. In addition, probe II hybridized to both the chromosome 9-12 and chromosome 22 spots (data not shown). Thus, restriction fragments from the center of the vWF cDNA (probes II and III) were not specific for the vWF locus on chromosome 12 .
The hybridization to the chromosome 9-12 spot ( Fig. 2 chromosome 12 (Fig. 3, A and B) . Total human genomic DNA and DNA from the hybrid cell line was digested with restriction enzymes for agarose gel electrophoresis and Southern blotting with cDNA probe III. Bands detected in both the human (H) and mouse-human hybrid (M) digests were assigned to human chromosome 12 . Bands detected only in total human genomic DNA (H) are labeled with arrows in Fig. 3 and are presumed to have originated from chromosome 22. The assignment to chromosome 22 of two bands detected in Sst I digests of human genomic DNA (Fig. 3 B) was confirmed by their detection in DNA from purified flow-sorted human chromosome 22 (Fig. 3 (Fig. 4) . The parents of patient S.G. were first cousins, so it is likely that he is homozygous for a single type of defect. The extent of deletion may be different for each of the mutant alleles of patient C.K. A total of 25 or 26 bands was detected with probes I-IV in DNA from normal controls and unaffected relatives, compared with only five or six bands in DNA from S.G. or C.K., respectively.
The heterozygous parents of C.K. and S.G. are expected to have half of the hybridizing DNA of normal controls. Such a gene dosage effect is not uniformly apparent in Fig. 4 , reflecting the difficulty in quantifying gene dosage by the unstandardized The extent of vWF gene deletion in patients S.G. and C.K.
A single band of 8.4 kb was detected with probe I in the DNA of both patient C.K. and S.G. (Fig. 4 A) . The origin of this band was investigated with subfragments of probe I. The same band was detected in both patients and control DNA with probe IA, whereas neither patient exhibited any ofthe three bands detected in control DNA with probe IB (Fig. 5 ), nor the 6.8-kb and 0.9-kb bands detected with probe IC (data not shown). The relative intensity of the hybridization signal for patient C.K. appears reduced in Fig. 5 A, but in other blots it is identical to normal controls (data not shown). The DNA from patients C.K. and G.S. did not hybridize to probe IB (Fig. 5 B) or probe IV (Fig. 4 D) vWF gene of both families, which seems very unlikely. The five or six bands detected by probes II and III for these patients (Fig.   4 , B and C) are consistent with their localization to chromosome 22, not to the vWF locus. This has been confirmed directly by examination of Eco RI-digested DNA from a mouse-human hybrid cell line that contains only human chromosome 22. However, these data do not exclude the possibility that fragments of the same mobility might be derived from both chromosome 12 and chromosome 22. In fact, the 12.1-kb and 1.15-kb bands detected with probe II (Fig. 4 B) , and the 15.5-kb band detected with probe III (Fig. 4 C) are present in DNA prepared from mouse-human hybrid cells containing either human chromosome 12 or 22, suggesting that both loci contain homologous Eco RI fragments of similar size (data not shown). Probe III reveals a potential polymorphism at the chromosome 22 locus. The normal controls, patient C.K and her relatives, exhibit a pair of bands at 15.5 and 11.5 kb, whereas patient S.G. and his relatives show only the band at 15.5 kb (Fig. 4 C) . Probe III also detects a band at 1.85 kb in some controls but in no patients or relatives. This band cannot yet be assigned to a specific chromosome.
The simplest interpretation of these data is that both C.K and G.S. have large deletions in both vWF alleles corresponding to at least the 3'-7.4 kb ofthe vWF cDNA. Over 60 kb ofgenomic DNA have been partially characterized that encode the cDNA of probes III and IV (34) . Another 60 kb of Eco RI bands on chromosome 12 was detected by probes I and II (Table I) . Thus the vWF gene spans at least -120 kb, and the size of these deletions probably exceeds 1 10 kb in both patients.
Discussion
We have demonstrated that fragments of the vWF cDNA hybridize not only to the vWF locus on chromosome 12 but also to sequences on chromosome 22. The conditions ofhybridization were very stringent, so that the cross-hybridizing locus should be highly homologous to vWF. In fact, several of the Eco RI fragments detected with probes II and III are of similar or identical size from both the chromosome 12 and chromosome 22 loci. The 5'-and 3'-boundaries ofthe cDNA segment responsible (Fig. 4 B) is not consistently visible and may represent partial digestion of a fragment from chromosome 22. The apparently polymorphic band at 1.85 kb detected with probe III in some normal controls could not be assigned to a specific locus.
for this cross-hybridization have not been defined precisely, but must lie between probes IC and IV (Fig. 1) (12, 15) . However, the genes for these proteins are on chromosome 6 (36) . The identification of gene deletion in two patients with vWD provides the first definitive proof that at least some forms of vWD are actually caused by lesions in the vWF gene. The two patients described in this report with severe vWD due to gene deletions have high-titer precipitating alloantibodies to transfused vWF, and neither has detectable endogenous plasma vWF (16, 32, 33) . All other patients studied showed normal hybridization patterns with all four cDNA probes and also exhibited immune tolerance to vWF. The hypothesis has been advanced that antibodies should develop in patients with large gene deletions who can make no recognizable vWF at all (16) , and this is consistent with our findings. Four affected siblings with severe vWD from a third kindred have recently been found to have a more extensive deletion ofthe vWF gene, and three ofthe four patients received multiple infusions of vWF and had developed alloantibodies to it (37) .
The interplay between specific alterations in gene structure, exposure to the exogenous gene product by transfusion, and the host immune system is not fully understood. Failure to express any protein epitope might be sufficient to elicit antibodies to that epitope in a patient with the appropriate immune responsiveness. In this regard, certain kinds ofgenetic lesions could be more effective than others in preventing the expression ofprotein antigens. For (18) (19) (20) (21) . As suggested by Giannelli and Brownlee (21) , determination ofthe epitope specificity ofalloantibodies to factor VIII, factor IX, and vWF should help us to understand these observations.
